Point-of-Care (POC) Coagulation Testing Market Growing a Remarkable CAGR of 4.61% by 2029, Key Drivers, Demand and Opportunity Analysis

The large scale  POC Coagulation Testing Market research report is extensive as well as object-oriented which has been formulated with the nice combination of an admirable industry experience, talent solutions, industry insight and most modern tools and technology. The report has been produced by taking into account the market type, size of the organization, accessibility on-premises and the end-users' organization type, and availability at global level in areas such as North America, South America, Europe, Asia-Pacific, Middle East and Africa. The credible POC Coagulation Testing Market report gives precise information about market trends, industrial changes, and consumer behaviour etc.

POC Coagulation Testing Market document helps disclose ambiguities that may happen due to changes in business activities or entry of a new product in the market. Under market definition topic of this report, market drivers which indicate the factors causing rise in the market growth and market restraints which indicate the factors causing fall in the market growth have been explored. The report also showcases important product developments and tracks recent acquisitions, mergers and research in the Healthcare industry by the key players of the market. Global POC Coagulation Testing Marketing report not only works to compete but also to outshine the competition.

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-poc-coagulation-testing-market

Data Bridge Market Research analyses that the point-of-care (POC) coagulation testing market which was USD 1,079.12 million in 2021, is expected to reach USD 1953.42 million by 2029, at a CAGR of 4.61% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Point-of-care coagulation testing (POCCT) allows clinicians to quickly assess a patient's coagulation status in real time. POCCT has several advantages over standard coagulation assays. As a result, there is growing interest in using POCCT in a wide range of clinical settings, including trauma, cardiac surgery, obstetrics, liver disease, and burns. POC coagulation testing allows for rapid clinical decisions in haematological interventions and, when used in conjunction with a proper transfusion algorithm, may reduce blood product usage and potentially complications associated with blood transfusion.

Global Point-of-Care (POC) Coagulation Testing Market Dynamics

Drivers

Significant consumption of anticoagulant drugs

Anticoagulant drugs, also known as blood thinners which helps to reduce the chances of atrial fibrillation-related heart strokes about 75%. The growing consumption of these drugs is driving the need for coagulation testing procedures to monitor blood clotting. This demand will lead to the expansion of the point-of-care (POC) coagulation testing market during the forecast period.

Automation in POC coagulation testing products

The growth of automated POC coagulation testing products is growing due to surging demand, automatic data uploading, and minimal human efforts. This has helped medical practitioners to perform rapid testing with minimal intervention. The automation in POC coagulation testing products is expected to have a positive impact on the overall market growth.

Some of the major players operating in the point-of-care (POC) coagulation testing market are:

Abbott (U.S.)
Danaher (U.S.)
Siemens (Germany)
Sysmex Corporation (U.S.)
Thermo Fisher Scientific Inc.  (U.S.)
Horiba Ltd.  (Japan)
Nihon Kohden Corporation (Japan)
F. Hoffmann-La Roche Ltd (Switzerland)
Maccura Biotechnology Co. Ltd. (China)
Bio Group Medical System (Italy)
Genrui Biotech Co. Ltd. (China)
A&T Corporation (Japan)
Beijing Succeeder Technology Inc. (China)
Diagnostica Stago SAS (France)
Helena Laboratories Corporation (U.S.)
Hycel (Austria)

 Browse More Reports

https://dbmrmarkett.blogspot.com/2023/07/microsporidiosis-treatment-market.html

https://dbmrmarkett.blogspot.com/2023/07/liposuction-devices-market-industry.html

https://dbmrmarkett.blogspot.com/2023/07/north-america-laboratory-information.html

https://dbmrmarkett.blogspot.com/2023/07/europe-fiber-optic-gyroscope-market.html

About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: - corporatesales@databridgemarketresearch.com

This release was published on openPR.